About RUN domain-containing protein 3A
RUN domain-containing protein 3A (RUNDC3A) is a protein
from Homo sapiens identified by UniProt accession
Q59EK9, 446 residues long.
MolForge cross-references it against 0 known binders and
35 disease associations.
Target properties
| Protein name | RUN domain-containing protein 3A |
| UniProt accession | Q59EK9 |
| Gene | RUNDC3A |
| Organism | Homo sapiens |
| Length | 446 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (35)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.31
- eosinophil count · score 0.26
- monocyte percentage of leukocytes · score 0.18
- granulocyte percentage of myeloid white cells · score 0.06
- atypical teratoid rhabdoid tumor · score 0.05
- glioblastoma multiforme · score 0.04
- ependymoma · score 0.03
- astrocytoma · score 0.03
- lung carcinoma · score 0.03
- Ataxia-telangiectasia · score 0.02
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q59EK9-F1 | alphafold | PREDICTED | 68.17 | — |
Amino-acid sequence (446 residues)
MEASFVQTTM ALGLSSKKAS SRNVAVERKN LITVCRFSVK TLLEKYTAEP IDDSSEEFVN FAAILEQILS HRFKACAPAG PVSWFSSDGQ RGFWDYIRLA CSKVPNNCVS SIENMENIST ARAKGRAWIR VALMEKRMSE YITTALRDTR TTRRFYDSGA IMLRDEATIL TGMLIGLSAI DFSFCLKGEV LDGKTPVVID YTPYLKFTQS YDYLTDEEER HSAESSTSED NSPEHPYLPL VTDEDSWYSK WHKMEQKFRI VYAQKGYLEE LVRLRESQLK DLEAENRRLQ LQLEEAAAQN QREKRELEGV ILELQEQLTG LIPSDHAPLA QGSKELTTPL VNQWPSLGTL NGAEGASNSK LYRRHSFMST EPLSAEASLS SDSQRLGEGT RDEEPWGPIG KDPTPSMLGL CGSLASIPSC KSLASFKSNE CLVSDSPEGS PALSPS
Explore RUN domain-containing protein 3A with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets